Placement Announced
Scancell Holdings placement
US$54.1m raised
Announced 23 Jul 2026 · AIM: SCLP · US$0.12 cash per share
Advisers
Lead managers
- Legal adviser
- Placement agent
- TD Securities (as TD Cowen)
- Issuer
- Scancell Holdings
- Issuer based in
- United Kingdom
- Sector
- Biotech
- Tags
- Biotech, Oncology
Similar deals
- Remix Therapeutics placement Jun 2026 · US$100m · Biotech
- Pyxis Oncology equity raising Sep 2026 · US$110m · Biotech
- BlossomHill Therapeutics IPO Aug 2026 · US$150m · Biotech
- Perspective Therapeutics equity raising Feb 2026 · US$175m · Radiopharmaceuticals
- Sensei Biotherapeutics placement Feb 2026 · US$200m · Biotech
Sources
- 23 Jul 2026 Scancell to Acquire Neuphoria, Concurrent $89 Million Private Financing cooley.com
- 24 Jul 2026 Press release (EX-99.1, exhibit), THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS sec.gov
